Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Julia Hedlund Lindberg"'
Autor:
Emma Ivansson, Julia Hedlund Lindberg, Karin Stålberg, Karin Sundfeldt, Ulf Gyllensten, Stefan Enroth
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Ovarian cancer is the 8th most common cancer among women and has a 5-year survival of only 30–50%. While the survival is close to 90% for stage I tumours it is only 20% for stage IV. Current biomarkers are not sensitive nor specific enough
Externí odkaz:
https://doaj.org/article/25b468e7601b4085bdac64b08aadb021
Autor:
Julia Hedlund Lindberg, Anna Widgren, Emma Ivansson, Inger Gustavsson, Karin Stålberg, Ulf Gyllensten, Karin Sundfeldt, Jonas Bergquist, Stefan Enroth
Publikováno v:
iScience, Vol 27, Iss 2, Pp 109001- (2024)
Summary: Early detection is key for increased survival in ovarian cancer, but no general screening program exists today due to lack of biomarkers and overall cost versus benefit over traditional clinical methods. Here, we used dried cervico-vaginal f
Externí odkaz:
https://doaj.org/article/9216e809903b445ca51db82f08bd1651
Autor:
Stefan Enroth, Emma Ivansson, Julia Hedlund Lindberg, Maria Lycke, Jessica Bergman, Anna Reneland, Karin Stålberg, Karin Sundfeldt, Ulf Gyllensten
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-13 (2022)
Enroth et al. validate their previously developed 11-biomarker plasma protein-based risk-score for distinguishing benign vs. malignant ovarian tumors. The risk score is found to be informative of treatment outcome and predictive of 5-year survival.
Externí odkaz:
https://doaj.org/article/f535e2e5697b4fbe93be405fe600836d
Autor:
Ruth S. Hermansson, Matts Olovsson, Inger Gustavsson, Ulf Gyllensten, Olga Lindkvist, Julia Hedlund Lindberg, Gabriella Lillsunde-Larsson, Annika K. Lindström
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Purpose Cervical cancer prevention for older women can be challenging since there are no specific guidelines for this group. This study aimed to determine the incidence of oncogenic HPV and HPV-related dysplasia in elderly women 5 years afte
Externí odkaz:
https://doaj.org/article/4f3d6f2c9e4d4f3383523c91b57de7dc
Autor:
Malin Berggrund, Inger Gustavsson, Riina Aarnio, Julia Hedlund Lindberg, Karin Sanner, Ingrid Wikström, Stefan Enroth, Ignas Bunikis, Matts Olovsson, Ulf Gyllensten
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-9 (2020)
Abstract Background The vaginal microbiota has been reported to be associated with HPV infection and cervical cancer. This study was performed to compare the vaginal microbiota at two timepoints in women performing self-sampling and had a persistent
Externí odkaz:
https://doaj.org/article/fdcacec767ab420e847436c6306a79f3
Autor:
Annika Kristina Lindström, Ruth Sanchez Hermansson, Inger Gustavsson, Julia Hedlund Lindberg, Ulf Gyllensten, Matts Olovsson
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0207714 (2018)
BackgroundAbout 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary aim was to evaluate the acceptability of repeated self-sampling at home for HPV-testing in elderly women. The prevalence of HPV and HPV related dyspl
Externí odkaz:
https://doaj.org/article/1df97df02b214fc7b99e1493ed48f372
Autor:
Enroth, Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke, Tomas Axelsson, Ulrika Liljedahl, Jessica Nordlund, Per-Henrik Edqvist, Tobias Sjöblom, Mathias Uhlén, Karin Stålberg, Karin Sundfeldt, Mikael Åberg, Stefan
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1757
Background: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30–50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have in
Autor:
Ruth S. Hermansson, Matts Olovsson, Inger Gustavsson, Ulf Gyllensten, Olga Lindkvist, Julia Hedlund Lindberg, Gabriella Lillsunde-Larsson, Annika K. Lindström
Purpose Cervical cancer prevention for older women can be challenging since there are no specific guidelines for this group. This study aimed to determine the incidence of oncogenic HPV and HPV-related dysplasia in elderly women 5 years after being H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cd1bf077614834192fe533576a7cad
https://doi.org/10.21203/rs.3.rs-1079060/v1
https://doi.org/10.21203/rs.3.rs-1079060/v1
Autor:
Malin Berggrund, Julia Hedlund-Lindberg, Matts Olovsson, Ulf Gyllensten, Stefan Enroth, Karin Sanner, Inger Gustavsson, Riina Aarnio, Ingrid Wikström
Publikováno v:
Virology Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Virology Journal
Virology Journal
Objective This study was performed to evaluate the use of high-risk HPV (hrHPV) viral load in screening tests for cervical cancer to predict persistent infection and presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+). Methods We
Autor:
Riina Aarnio, Ulf Gyllensten, Ingrid Wikström, Matts Olovsson, Malin Berggrund, Julia Hedlund-Lindberg, Stefan Enroth, Inger Gustavsson, Karin Sanner
Publikováno v:
International Journal of Cancer. 144:89-97
We conducted a randomised study to compare vaginal self-sampling with assisted sampling by medical personnel on the cervix for HPV testing in primary screening. The first aim was to determine if th ...